Levodopa/carbidopa microtablets in Parkinson’s disease: a study of pharmacokinetics and blinded motor assessment
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1041
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Levodopa/carbidopa microtablets in Parkinson’s disease: a study of pharmacokinetics and blinded motor assessment ; day:18 ; month:1 ; year:2017 ; pages:1-9
European journal of clinical pharmacology ; (18.1.2017), 1-9
- Schlagwort
-
Hirnkrankheit
Neuropsychiatrie
Nervenkrankheit
- Urheber
-
Senek, Marina
- Beteiligte Personen und Organisationen
-
Aquilonius, Sten-Magnus
Askmark, Hakan
Bergquist, Filip
Constantinescu, Radu
Ericsson, Anders
Lycke, Sara
Medvedev, Alexander
Memedi, Mevludin
Ohlsson, Fredrik
SPIRA, JACK
Westin, Jerker
Nyholm, Dag
SpringerLink (Online service)
- DOI
-
10.1007/s00228-017-2196-4
- URN
-
urn:nbn:de:1111-201702157577
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Senek, Marina
- Aquilonius, Sten-Magnus
- Askmark, Hakan
- Bergquist, Filip
- Constantinescu, Radu
- Ericsson, Anders
- Lycke, Sara
- Medvedev, Alexander
- Memedi, Mevludin
- Ohlsson, Fredrik
- SPIRA, JACK
- Westin, Jerker
- Nyholm, Dag
- SpringerLink (Online service)
Ähnliche Objekte (12)
Population pharmacokinetics of levodopa/carbidopa microtablets in healthy subjects and Parkinson’s disease patients
Motor fluctuations due to interaction between dietary protein and levodopa in Parkinson’s disease
Disentangling nigral and putaminal contribution to motor impairment and levodopa response in Parkinson’s disease
Disentangling nigral and putaminal contribution to motor impairment and levodopa response in Parkinson’s disease
Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease
Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson’s Disease
Embelin and levodopa combination therapy for improved Parkinson’s disease treatment
Gut bacterial deamination of residual levodopa medication for Parkinson’s disease
Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease
Helicobacter pylori infection and Parkinson’s Disease: etiology, pathogenesis and levodopa bioavailability
PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson’s Disease
Long-term treatment of Parkinson’s disease with levodopa and other adjunctive drugs
Population pharmacokinetics of levodopa/carbidopa microtablets in healthy subjects and Parkinson’s disease patients
Motor fluctuations due to interaction between dietary protein and levodopa in Parkinson’s disease
Disentangling nigral and putaminal contribution to motor impairment and levodopa response in Parkinson’s disease
Disentangling nigral and putaminal contribution to motor impairment and levodopa response in Parkinson’s disease
Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease
Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson’s Disease
Embelin and levodopa combination therapy for improved Parkinson’s disease treatment
Gut bacterial deamination of residual levodopa medication for Parkinson’s disease
Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease
Helicobacter pylori infection and Parkinson’s Disease: etiology, pathogenesis and levodopa bioavailability
PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson’s Disease
Long-term treatment of Parkinson’s disease with levodopa and other adjunctive drugs
Population pharmacokinetics of levodopa/carbidopa microtablets in healthy subjects and Parkinson’s disease patients
Motor fluctuations due to interaction between dietary protein and levodopa in Parkinson’s disease
Disentangling nigral and putaminal contribution to motor impairment and levodopa response in Parkinson’s disease
Disentangling nigral and putaminal contribution to motor impairment and levodopa response in Parkinson’s disease
Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease
Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson’s Disease
Embelin and levodopa combination therapy for improved Parkinson’s disease treatment
Gut bacterial deamination of residual levodopa medication for Parkinson’s disease
Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease
Helicobacter pylori infection and Parkinson’s Disease: etiology, pathogenesis and levodopa bioavailability
PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson’s Disease